Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study
01 Pubblicazione su rivista
Lanini Simone, Scognamiglio Paola, Mecozzi Alessandra, Lombardozzi Lorella, Vullo Vincenzo, Angelico Mario, Gasbarrini Antonio, Taliani Gloria, Attili Adolfo Francesco, Perno Carlo Federico, De Santis Adriano, Puro Vincenzo, Cerqua Fabio, D'Offizi Gianpiero, Pellicelli Adriano, Armignacco Orlando, Mennini Francesco Saverio, Siciliano Massimo, Girardi Enrico, Panella Vincenzo, Ippolito Giuseppe, Mastroianni Claudio, d'Ettorre Gabriella, Lichtner Miriam, Accapezzato D, GINANNI CORRADINI Stefano, Mezzaroma Ivano, members of the Lazio Region HCV treatment Group, Gentile Giuseppe
ISSN: 1471-2334
Management of chronic hepatitis C (CHC) has significantly accelerated in the last few years. Currently, second generation direct acting antivirals (DAAs) promise clearance of infection in most of patients. Here we present the results of the first analysis carried out on data of Lazio clinical network for DAAs.